Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 619 of 1,261

  1. US 9713459

    Method and system for in vivo hydrogen peroxide detection with ultrasound

    The Regents of the University of California · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted

  2. US 9708595

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  3. US 9708359

    Pyrrolopyrimidine nucleosides and analogs thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  4. US 9708313

    Substituted pyrido[3,4-b]pyrazines as GPR6 modulators

    Takeda Pharmaceutical Company Limited · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  5. US 9708310

    Phenanthroindolizidine and phenanthroquinolizidine alkaloid having a hydroxyl group on the phenanthrene ring thereof, preparation method and use thereof

    China Medical University · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  6. US 9708291

    Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl)-(2-chlorophenyl)-methanone

    VANDA PHARMACEUTICALS INC. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  7. US 9708247

    Modulators of the eIF2alpha pathway

    The Regents of the University of California · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  8. US 9707315

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  9. US 9707295

    Inhalable medicament

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  10. US 9707293

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  11. US 9707292

    Lipids and compositions for the delivery of therapeutics

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  12. US 9707287

    Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  13. US 9708615

    Therapeutic compositions

    Alnylam Pharmaceuticals, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  14. US 9707285

    Vaccination methods

    TURNSTONE LIMITED PARTNERSHIP · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  15. US 9707283

    Genetically modified babesia parasites expressing protective tick antigens and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  16. US 9707284

    Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases

    The Regents of the University of California · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  17. US 9707281

    Pharmaceutical compositions and methods for digesting atherosclerotic plaques

    Northwestern University · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  18. US 9707270

    Method for administering ω-conopeptide

    Jazz Pharmaceuticals International III Limited · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  19. US 9707223

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  20. US 9707252

    Synthetic sealants

    Covidien LP · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  21. US 9707221

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  22. US 9707239

    Compounds that modulate oxidative stress

    VTV THERAPEUTICS LLC · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  23. US 9707220

    Scopolamine for the treatment of depression and anxiety

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  24. US 9707256

    Methods of making endothelial scaffolds

    Wake Forest Institute for Regenerative Medicine · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.